Snowwater Investment Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.29M Sell
1,077
-39
-3% -$39.8K 0.89% 27
2026
Q1
$1.03M Buy
1,116
+78
+8% +$79.1K 0.97% 28
2025
Q4
$1.12M Buy
+1,038
New +$993K 1.03% 27

Other funds holding LLY

Snowwater Investment Partners's LLY Position: Q2 2026 in Review

Snowwater Investment Partners reduced its Eli Lilly (LLY) stake by 3.5% in Q2 2026, selling an estimated $39.8K and leaving 1,077 shares worth $1.29M. The position accounts for 0.89% of the portfolio, ranked #27.

Snowwater Investment Partners first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Snowwater Investment Partners held 1,077 shares of Eli Lilly worth $1.29M as of Q2 2026.
  • Snowwater Investment Partners sold 39 Eli Lilly shares in Q2 2026, an estimated $39.8K.
  • Eli Lilly made up 0.89% of Snowwater Investment Partners's portfolio in Q2 2026, its #27 holding.
  • Snowwater Investment Partners first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Snowwater Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.